Literature DB >> 31026418

Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3)-Mixed Lineage Kinase Domain-Like Protein (MLKL)-Mediated Necroptosis Contributes to Ischemia-Reperfusion Injury of Steatotic Livers.

Hong-Min Ni1, Xiaojuan Chao2, Joshua Kaseff2, Fengyan Deng2, Shaogui Wang2, Ying-Hong Shi3, Tiangang Li2, Wen-Xing Ding2, Hartmut Jaeschke2.   

Abstract

Increased hepatic ischemia-reperfusion (IR) injury in steatotic livers is a major reason for rejecting the use of fatty livers for liver transplantation. Necroptosis is implicated in the pathogenesis of fatty liver diseases. Necroptosis is regulated by three key proteins: receptor-interacting serine/threonine-protein kinase (RIPK)-1, RIPK3, and mixed-lineage kinase domain-like protein (MLKL). Here, we found that marked steatosis of the liver was induced when a Western diet was given in mice; steatosis was associated with the inhibition of hepatic proteasome activities and with increased levels of key necroptosis-related proteins. Mice fed a Western diet had more severe liver injury, as demonstrated by increases in serum alanine aminotransferase and necrotic areas of liver, after IR than did mice fed a control diet. Although hepatic steatosis was not different between Mlkl knockout mice and wild-type mice, Mlkl knockout mice had decreased hepatic neutrophil infiltration and inflammation and were protected from hepatic IR injury, irrespective of diet. Intriguingly, Ripk3 knockout or Ripk3 kinase-dead knock-in mice were protected against IR injury at the late phase but not the early phase, irrespective of diet. Overall, our findings indicate that liver steatosis exacerbates hepatic IR injury via increased MLKL-mediated necroptosis. Targeting MLKL-mediated necroptosis may help to improve outcomes in steatotic liver transplantation.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31026418      PMCID: PMC6698941          DOI: 10.1016/j.ajpath.2019.03.010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

Review 1.  Regulation of inflammatory vascular damage.

Authors:  A B Lentsch; P A Ward
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 2.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.

Authors:  Hartmut Jaeschke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01       Impact factor: 4.052

3.  The disease burden associated with overweight and obesity.

Authors:  A Must; J Spadano; E H Coakley; A E Field; G Colditz; W H Dietz
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

4.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

Review 5.  Role of microcirculation in transplantation.

Authors:  M D Menger; B Vollmar
Journal:  Microcirculation       Date:  2000-10       Impact factor: 2.628

Review 6.  Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.

Authors:  Hartmut Jaeschke; John J Lemasters
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

Review 7.  Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion.

Authors:  Tomohisa Okaya; Alex B Lentsch
Journal:  J Invest Surg       Date:  2003 May-Jun       Impact factor: 2.533

8.  A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.

Authors:  Songqing He; Carl Atkinson; Zachary Evans; Justin D Ellett; Mark Southwood; Andrew Elvington; Kenneth D Chavin; Stephen Tomlinson
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Necrostatin: a potentially novel cardioprotective agent?

Authors:  Christopher C T Smith; Sean M Davidson; Shiang Y Lim; James C Simpkin; John S Hothersall; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2007-07-31       Impact factor: 3.727

10.  Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice.

Authors:  Tadashi Hasegawa; Yoshiya Ito; Jayanthika Wijeweera; Jie Liu; Ernst Malle; Anwar Farhood; Robert S McCuskey; Hartmut Jaeschke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-02-15       Impact factor: 4.052

View more
  21 in total

Review 1.  The potential role of necroptosis in inflammaging and aging.

Authors:  Gordon H Royce; Holly M Brown-Borg; Sathyaseelan S Deepa
Journal:  Geroscience       Date:  2019-11-13       Impact factor: 7.713

2.  Aging aggravated liver ischemia and reperfusion injury by promoting hepatocyte necroptosis in an endoplasmic reticulum stress-dependent manner.

Authors:  Weizhe Zhong; Xiaowei Wang; Zhuqing Rao; Xiongxiong Pan; Yu Sun; Tao Jiang; Ping Wang; Haoming Zhou; Xuehao Wang
Journal:  Ann Transl Med       Date:  2020-07

3.  Schwann cell necroptosis in diabetic neuropathy.

Authors:  Alexia Belavgeni; Francesca Maremonti; Marlena Stadtmüller; Stefan R Bornstein; Andreas Linkermann
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-21       Impact factor: 12.779

Review 4.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

5.  Cell-specific activation of RIPK1 and MLKL after intracerebral hemorrhage in mice.

Authors:  Sevda Lule; Limin Wu; Aliyah Sarro-Schwartz; William J Edmiston; Saef Izzy; Tanya Songtachalert; So Hee Ahn; Neil D Fernandes; Gina Jin; Joon Yong Chung; Siddharth Balachandran; Eng H Lo; David Kaplan; Alexei Degterev; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-19       Impact factor: 6.200

Review 6.  Necroptosis in the Pathophysiology of Disease.

Authors:  Mitri K Khoury; Kartik Gupta; Sarah R Franco; Bo Liu
Journal:  Am J Pathol       Date:  2019-11-26       Impact factor: 4.307

7.  Cyclin-Dependent Kinase 9 Inhibition Suppresses Necroptosis and Pyroptosis in the Progress of Endotoxemia.

Authors:  Jiao Li; Huimin Mao; Yue Pan; Houxuan Li; Lang Lei
Journal:  Inflammation       Date:  2020-12       Impact factor: 4.092

Review 8.  Different types of cell death in vascular diseases.

Authors:  Shirin Saberianpour; Abbas Karimi; Mohammad Hadi Saeed Modaghegh; Mahdi Ahmadi
Journal:  Mol Biol Rep       Date:  2021-05-19       Impact factor: 2.316

9.  Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in mice.

Authors:  Mohammad Javad Khodayar; Heibatullah Kalantari; Layasadat Khorsandi; Nematollah Ahangar; Azin Samimi; Hadis Alidadi
Journal:  Mol Biol Rep       Date:  2021-05-25       Impact factor: 2.316

Review 10.  The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease.

Authors:  Emma C Tovey Crutchfield; Sarah E Garnish; Joanne M Hildebrand
Journal:  Biomolecules       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.